Managing Distress in the Cannabis Industry – Meeting Challenges and Opportunities
Managing Distress in the Cannabis Industry – Meeting Challenges and Opportunities
This interactive panel will explore both sources and implications of industry volatility, possible avenues for distressed companies and the possible future economic horizon.
Topics to be discussed include:
- Causes and Implications of 2019-20 Industry Volatility
- Confronting Lingering Headwinds
- Assessing when M&A is a Realistic Solution for Distressed Cannabis Companies
- Current Legal Options and Opportunities Concerning Distressed Cannabis Businesses
- Pursuing Creditors Rights and Remedies
- Eyeing the Horizon – Projections through 2021
When
Wednesday, September 9, 2020
10:00 p.m. - 11:00 a.m. PT
12:00 p.m. - 1:00 p.m. CT
1:00 p.m. - 2:00 p.m. ET
Where
Zoom Webinar
*Webinar details will be emailed to you after you register*
Complimentary Program
Presented By:
- Alan Martin, Partner, Sheppard Mullin
- Zac Turke, Partner, Sheppard Mullin
- Nicholas Wilson, Chief Operating Officer, Douglas Wilson Companies, President, KND Labs
MCLE*
CA
This activity has been approved for Minimum 1 Continuing Legal Education credit by the State Bar of California. Sheppard Mullin Richter & Hampton LLP certifies that this activity conforms to the standards for approved education activities prescribed by the rules and regulations of the State Bar of California governing minimum continuing legal education.
NY
This program has been approved in accordance with the requirements of the New York State Continuing Legal Education Board for a maximum of 1 credit hour which may be applied toward the Areas of Professional Practice requirement, and is suitable for both transitional and non-transitional attorneys.
MCLE attendance certificates will be distributed following the webinar upon completion of an evaluation.
*You must attend the full webinar to receive credit
Click here for more information on Sheppard Mullin's Cannabis Team.
For up-to-date information and recent developments, visit our Coronavirus (COVID-19) Insights page.
Questions? Contact Belinda Ashong via email.
